多基因风险评分分析临床转化方面的挑战:系统性审查
Diana Martínez-Minguet1, René Noel2, Alberto G Simón1
1PROS Group, Valencian Research Institute for Artificial Intelligence (VRAIN), Universitat Politècnica de València, Camí de Vera, València, Spain.
概括
在临床实践中实施多基因风险评分 (PRS) 分析面临挑战. 本次审查确定了关键障碍和解决方案,以指导PRS在医疗保健中的整合.
科学领域:
- 基因组学和精准医学精准医学
- 临床生物信息学 临床生物信息学
- 翻译研究是翻译研究.
背景情况:
- 多基因风险评分 (PRS) 分析在临床实践中越来越多地被认为具有潜力.
- 然而,重大实施障碍阻碍了整个医疗保健系统的广泛采用.
- 关于这些障碍的现有研究是分散的,需要进行全面的综合.
研究的目的:
- 在临床实践中系统地识别,分类和综合多基因风险评分 (PRS) 分析的实施挑战.
- 从现有文献中绘制出拟议的解决方案及其验证.
- 提供结构化的概述,以指导未来的研究和临床整合努力.
主要方法:
- 根据PRISMA指南进行了系统的文献审查.
- 在PubMed,Scopus和Web of Science数据库 (2020-2025) 中进行了搜索.
- 包括的研究分析了已识别的挑战,建议的解决方案和验证数据,并对挑战进行了分类.
主要成果:
- 包括54项研究,确定了8个主要挑战类别.
- 其中包括PRS模型报告中的异质性,选择复杂性,技术障碍以及缺乏指导方针/工作流.
- 在解决这些已识别的挑战方面,研究努力和清晰度不均.
结论:
- 本综述提供了PRS实施挑战和相关解决方案的结构化目录.
- 仍然存在显著的差距,特别是在需要协调研究努力的领域.
- 将PRS有效和负责任地整合到临床护理中,需要解决这些已识别的缺口.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
375
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
375
Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K
Polygenic Traits
68.8K
When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
68.8K
Bias in Epidemiological Studies
1.2K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.2K
Single Nucleotide Polymorphisms-SNPs
17.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.8K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
358
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
358


